Indication
Rheumatoid arthritis
Rheumatoid arthritis is a chronic, systemic autoimmune inflammatory disorder that primarily targets the synovial membrane of diarthrodial joints. Read more about Rheumatoid arthritis
1,535 drugs 456 manufacturers
Drugs that treat it
Common Rheumatoid arthritis therapies.
HYDROXYCHLOROQUINE SULFATE
IBUPROFEN
INDOMETHACIN
KENALOG-10 (triamcinolone acetonide)
KENALOG-40 (triamcinolone acetonide)
LEFLUNOMIDE
MEDROL (methylprednisolone)
MELOXICAM
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonRheumatoid arthritis is a chronic, systemic autoimmune inflammatory disorder that primarily targets the synovial membrane of diarthrodial joints.
Although it can manifest at any age and exhibits a predilection for adult females, its clinical hallmark is persistent, symmetric polyarthritis affecting small peripheral joints—such as the metacarpophalangeal, proximal interphalangeal, and metatarsophalangeal joints—frequently presenting with morning stiffness, swelling, and tenderness.
Pathophysiologically, immune-mediated synovitis stimulates synovial hyperplasia, pannus formation, and enzymatic release, ultimately leading to progressive articular cartilage destruction and marginal bone erosions.
Left uncontrolled, the condition produces progressive joint deformities, chronic functional disability, and diverse extra-articular manifestations involving the pulmonary, cardiovascular, and ocular systems.
- nih.gov
Rheumatoid arthritis is a chronic, systemic autoimmune inflammatory disorder that primarily targets the synovial membrane of diarthrodial joints Although it can manifest at any age and exhibits a predilection for adult females, its clinical hallmark is persistent, symmetric polyarthritis affecting small peripheral joints—such as the metacarpophalangeal, proximal interphalangeal, and metatarsophalangeal joints—frequently presenting with morning stiffness, swelling, and tenderness Pathophysiologic...
- nih.gov
Rheumatoid arthritis is a chronic, systemic autoimmune inflammatory disorder that primarily targets the synovial membrane of diarthrodial joints
- nih.gov
Although it can manifest at any age and exhibits a predilection for adult females, its clinical hallmark is persistent, symmetric polyarthritis affecting small peripheral joints—such as the metacarpophalangeal, proximal interphalangeal, and metatarsophalangeal joints—frequently presenting with morning stiffness, swelling, and tenderness Pathophysiologically, immune-mediated synovitis stimulates synovial hyperplasia, pannus formation, and enzymatic release, ultimately leading to progressive artic...
- rheumatology.org
Although it can manifest at any age and exhibits a predilection for adult females, its clinical hallmark is persistent, symmetric polyarthritis affecting small peripheral joints—such as the metacarpophalangeal, proximal interphalangeal, and metatarsophalangeal joints—frequently presenting with morning stiffness, swelling, and tenderness
- nih.gov
Pathophysiologically, immune-mediated synovitis stimulates synovial hyperplasia, pannus formation, and enzymatic release, ultimately leading to progressive articular cartilage destruction and marginal bone erosions Left uncontrolled, the condition produces progressive joint deformities, chronic functional disability, and diverse extra-articular manifestations involving the pulmonary, cardiovascular, and ocular systems
- cdc.gov
Left uncontrolled, the condition produces progressive joint deformities, chronic functional disability, and diverse extra-articular manifestations involving the pulmonary, cardiovascular, and ocular systems
Personalize your experience
Follow Rheumatoid arthritis and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.